Among adults with COPD, the likelihood for having mucus plugs on CT can be determined using a tool that considers 11 “readily ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...

In an age where respiratory health has gained unprecedented attention, innovative solutions like Breathe Drops for Lungs are shaping how individuals approach breathing difficulties. This product ...

Dupilumab reduces mucus plugging and improves lung function in patients with moderate-to-severe type 2 asthma.

Researchers found that fewer dupilumab-receiving patients had high mucus plug scores at week 24 than at baseline (32.8 vs 67.2%). HealthDay News — Dupilumab reduces mucus plug scores and improves lung ...

(Boston)—Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading cause of death. Mucus plugging (mucus that accumulates in the lungs ...

An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. Results found half as many patients had mucus-plugged airways ...

Your lungs naturally cleanse themselves with mucus and cilia. Supporting this process involves avoiding irritants and incorporating practices like controlled coughing, steam therapy, and ...

After only 28 days of treatment with ARCT-032 (10 mg), 4 out of 6 Class I CF participants exhibited encouraging reduction of mucus plug number and mucus volume 12 ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) stock was trading lower on Wednesday after the company shared interim results from its ongoing Phase 2 trial of ARCT-032, an investigational inhaled ...

Detailed price information for Arcturus Therapeutics Ltd (ARCT-Q) from The Globe and Mail including charting and trades.